Guardion Health Sciences, Inc.
DelistedCIK 1642375fmd_1WTXZTR170584DNDX27AHHH043Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2015 to Jun 30, 2024, 35 periods
Latest annual · FY2023
Millions- Total revenues
- 12
- Gross profit
- 5
- Operating income
- (4)
- Net income
- 0
- Free cash flow
- (4)
Latest quarter · Q2 FY2024
Millions- Total revenues
- 0
- Gross profit
- 0
- Operating income
- (1)
- Net income
- 10
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2020 to FY2023
- +86.4%
- Revenue, 5 yearsFY2018 to FY2023
- +67.0%
- Net income, 5 yearsFY2018 to FY2023
- n/m
Guardion Health Sciences, Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2023 | FY2022 | Change | Source |
|---|---|---|---|---|
| Revenue | $12.2 million | $11 million | +10.8% | 10-K 2024-03-29 · proof |
| Gross profit | $5.4 million | $4.5 million | +19.3% | 10-K 2024-03-29 · proof |
| Operating income | -$4.3 million | -$17.4 million | 10-K 2024-03-29 · proof | |
| Net income | $158,033 | -$14.9 million | 10-K 2024-03-29 · proof | |
| Cash from operating activities | -$4.4 million | -$7.4 million | 10-K 2024-03-29 · proof | |
| Free cash flow | -$4.4 million | -$7.5 million | 10-K 2024-03-29 · proof | |
| Total assets | $11.9 million | $21.7 million | -45% | 10-K 2024-03-29 · proof |
| Total liabilities | $3.8 million | $8.5 million | -55.7% | 10-K 2024-03-29 · proof |
| Cash and cash equivalents | $6.4 million | $10.7 million | -40.3% | 10-K 2024-03-29 · proof |
- What was Guardion Health Sciences, Inc.'s revenue in fiscal 2023?
- Guardion Health Sciences, Inc. reported revenue of $12.2 million for fiscal 2023 (the year ended Dec 31, 2023), against $11 million the year before (+10.8%). Source: the 10-K filed with the SEC on Mar 29, 2024. SEC
- What was Guardion Health Sciences, Inc.'s gross profit in fiscal 2023?
- Guardion Health Sciences, Inc. reported gross profit of $5.4 million for fiscal 2023 (the year ended Dec 31, 2023), against $4.5 million the year before (+19.3%). Source: the 10-K filed with the SEC on Mar 29, 2024. SEC
- What was Guardion Health Sciences, Inc.'s operating income in fiscal 2023?
- Guardion Health Sciences, Inc. reported operating income of -$4.3 million for fiscal 2023 (the year ended Dec 31, 2023), against -$17.4 million the year before. Source: the 10-K filed with the SEC on Mar 29, 2024. SEC
- What was Guardion Health Sciences, Inc.'s net income in fiscal 2023?
- Guardion Health Sciences, Inc. reported net income of $158,033 for fiscal 2023 (the year ended Dec 31, 2023), against -$14.9 million the year before. Source: the 10-K filed with the SEC on Mar 29, 2024. SEC
- What was Guardion Health Sciences, Inc.'s cash from operating activities in fiscal 2023?
- Guardion Health Sciences, Inc. reported cash from operating activities of -$4.4 million for fiscal 2023 (the year ended Dec 31, 2023), against -$7.4 million the year before. Source: the 10-K filed with the SEC on Mar 29, 2024. SEC
- What was Guardion Health Sciences, Inc.'s free cash flow in fiscal 2023?
- Guardion Health Sciences, Inc. reported free cash flow of -$4.4 million for fiscal 2023 (the year ended Dec 31, 2023), against -$7.5 million the year before. Source: the 10-K filed with the SEC on Mar 29, 2024. SEC
- What are Guardion Health Sciences, Inc.'s total assets?
- As of Dec 31, 2023, Guardion Health Sciences, Inc. reported total assets of $11.9 million, against $21.7 million a year earlier (-45%). Source: the 10-K filed with the SEC on Mar 29, 2024. SEC
- What are Guardion Health Sciences, Inc.'s total liabilities?
- As of Dec 31, 2023, Guardion Health Sciences, Inc. reported total liabilities of $3.8 million, against $8.5 million a year earlier (-55.7%). Source: the 10-K filed with the SEC on Mar 29, 2024. SEC
- What are Guardion Health Sciences, Inc.'s cash and cash equivalents?
- As of Dec 31, 2023, Guardion Health Sciences, Inc. reported cash and cash equivalents of $6.4 million, against $10.7 million a year earlier (-40.3%). Source: the 10-K filed with the SEC on Mar 29, 2024. SEC
Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1642375&period_type=annual&limit=5"Information only, not investment advice.